ROARABLE
FREE $100K
My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Financials / HQH
BST (49) NCZ (44) JCAP (69) NCV (43) ⌘ Pro Terminal →

abrdn Healthcare Investors (HQH) — RQD Stock Rating Cockpit

$20.99 -1.87% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $20.88

abrdn Healthcare Investors (HQH) carries a Roarable Rating of D+ (Sell) with 54/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $1.01B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HQH Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is HQH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, abrdn Healthcare Investors (NYSE: HQH) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 54/100 at a spot price of $20.99 (-1.87% 1D, market cap $1.01B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 11/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 9/20. Across 1097 tracked Financials issuers, HQH ranks #553 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does HQH compare to BST and NCZ in the Financials sector?
▼

Within the Financials sector (Finance Companies), HQH carries a Roarable D+ (54/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, BST (BlackRock Science and Technology Trust of) holds a D grade (49/100 RQD, P/E N/A, ROIC —, cap $1.03B) and NCZ (Virtus Convertible & Income Fund II of) posts a D grade (44/100 RQD, P/E N/A, ROIC —, cap $1.07B). Among the 5-stock peer group, JCAP leads on earnings multiple (6.1x) while JCAP leads on capital efficiency (55.2% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HQH?
▼

For abrdn Healthcare Investors (HQH), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity and sector rank #553 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $20.88 (-0.53%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 0.7% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 54/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.7% avg 90D alpha vs SPY • 51.0% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D+
025507510054
Quant Analyst Panel Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw D+ · Rk D+
Cash (11)Whales (11)SEC (13)Macro (10)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE-1.8% Base Target
$26 Bull$21 Base$16 Bear
📬 FREE HQH RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HQH)Realized 20D OHLCV Swing Band: ±5.8%
Deterministic 5-Pillar Attribution (54/100 Composite)
🔍 WHY HQH SCORES 54/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (24% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+11/20 pts (20% of score)

SEC XBRL Trailing 12 Months: 0.7% FCF Margin ($28.4M FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
46
Grade D$19.13+5.6% Next Q
Q2 (-2Q)
49
Grade D$20.20+2.9% Next Q
Q3 (-1Q)
51
Grade C-$20.78+1% Next Q
Current
54
Grade D+$20.99-0.7% Hist 90D α
Trajectory: D (46) → D+ (54)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a HQH Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While HQH currently carries a cautious 54/100 (D+) rating due to Insider Conviction & Share Dilution (9/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($21.10) and Max Pain ($22.04) forces dealer call-delta covering toward $26.09.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HQH• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “HQH Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”
YES 54%NO 46%Trade / Inspect Odds →
RSI-14 MOMENTUMBULLISH MOMENTUM
61.830 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.80>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
7 / 99-Pt Accounting
52-WEEK LASER RANGE50% OF RANGE
L: $17$20.99H: $25
1. Money & Cash Health● MIXED
Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: D+RQD 11 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: DRQD 20 / 40
3. Hidden Risks & Market Weather● WATCH
SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: D+RQD 23 / 40
MULTI-MODEL QUANT PANEL DELIBERATION

Quant Analyst Panel Split (Battleground) on HQH

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
NEUTRAL (55)

14.0% ROIC with 42.0% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
NEUTRAL (65)

Altman-Z 4.20 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (50)

20/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like HQH
  • ✓Established market leader in Financials with deep daily trading liquidity.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HQH)

  • ✓Walkthrough of HQH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
HQH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +5.32%📐 HORIZONTAL RANGE
2026-11-03O $21.42H $21.42L $20.99C $20.99VOL 181.7K
RES: $26.28SUP: $18.39SMA50: $21.10SMA200: $20.34
$25.31$23.41$21.51$19.62$17.72RES $26.28SUP $18.39$20.992026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HQH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HQH Butterfly Map → + Track HQH →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on HQH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HQH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HQH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HQH)

Financials Rank #553 of 1097 ⚔️ BST vs HQH Full Matrix →

1. Head-to-Head Financials Peer Comparison (HQH vs. BST, NCZ, JCAP, NCV)

Industry: Finance Companies (27 Tracked Issuers)

Across 1097 tracked Financials securities in the Roarable RQD universe, abrdn Healthcare Investors (HQH) ranks #553 by composite RQD confidence (54/100, grade D+) and #550 by equity capitalization ($1.01B). Within this direct 5-issuer industry benchmark cohort, JCAP leads on earnings valuation at 6.1x trailing P/E, while JCAP leads on capital efficiency and profitability with 55.2% ROIC and — gross margin. JCAP currently holds the highest overall quantitative score in the immediate peer group at 69/100 (C+) compared with HQH at 54/100 (D+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
HQH ACTIVE
abrdn Healthcare Investors
D+ 54/100 — — — -1.87% $1.01B Benchmark Subject
BST
BlackRock Science and Technology Trust of
D 49/100 — — — -0.97% $1.03B /bst-vs-hqh →
NCZ
Virtus Convertible & Income Fund II of
D 44/100 — — — -0.07% $1.07B /ncz-vs-hqh →
JCAP
Jefferson Capital Inc.
C+ 69/100 6.1x — 55.2% +2.84% $1.13B /jcap-vs-hqh →
NCV
Virtus Convertible & Income Fund of
D- 43/100 — — — -1.26% $1.37B /ncv-vs-hqh →

2. HQH Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

abrdn Healthcare Investors (HQH) operates in Finance Companies (Financials) with an equity capitalization of $1.01B, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. HQH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HQH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, abrdn Healthcare Investors (NYSE: HQH) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 54/100 at a spot price of $20.99 (-1.87% 1D, market cap $1.01B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 11/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 9/20. Across 1097 tracked Financials issuers, HQH ranks #553 in composite RQD confidence.

How does HQH compare to BST and NCZ in the Financials sector?

Within the Financials sector (Finance Companies), HQH carries a Roarable D+ (54/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, BST (BlackRock Science and Technology Trust of) holds a D grade (49/100 RQD, P/E N/A, ROIC —, cap $1.03B) and NCZ (Virtus Convertible & Income Fund II of) posts a D grade (44/100 RQD, P/E N/A, ROIC —, cap $1.07B). Among the 5-stock peer group, JCAP leads on earnings multiple (6.1x) while JCAP leads on capital efficiency (55.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HQH?

For abrdn Healthcare Investors (HQH), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity and sector rank #553 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HQH trading relative to its 50-day, 200-day, and 52-week technical levels?

HQH last traded at $20.99 (-1.87% on volume of 165,896 shares), positioning the stock -0.52% below its 50-day simple moving average ($21.10) and +3.20% above its 200-day simple moving average ($20.34). Across its 52-week range of $17.14 to $24.85, HQH sits at the 49.9% percentile with a 14-day RSI of 61.8 (BULLISH MOMENTUM) and an implied next-earnings move of ±5.8% ($19.77 to $22.21).

Direct Sub-Reports: HQH RQD Cockpit HQH 12M Forecast HQH Earnings & Move HQH Dividends & DRIP HQH Insiders & 13F HQH Whale Options HQH Profit Sankey HQH News & Why
ROARABLE RATING BRIEF • RQD 54/100 (D+) ✓ SEC XBRL & RQD VERIFIED

HQH — abrdn Healthcare Investors: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-11-03

1. Roarable Rating Brief: What This Means to a Prospective Investor

abrdn Healthcare Investors (HQH) earns a live Roarable RQD composite score of 54/100, corresponding to a D+ letter grade (Roarable Sell) at a spot price of $20.99 (-1.87% 1D, market capitalization $1.01B).

  • Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of —, gross margin of —, operating margin of —, and free cash flow yield of —.
  • Whale 13F & Options Flow (11/20) + Insider Conviction (9/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (10/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of N/A, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

abrdn Healthcare Investors (HQH) is a NYSE-listed operating company in the Finance Companies industry (Financials sector) with an equity market capitalization of $1.01B. The business operates with a gross margin of 0%, an operating margin of 0%, and a return on invested capital (ROIC) of 0% (free cash flow yield of 0%). Within the Finance Companies peer group, investor evaluation centers on operating leverage, unit margin durability, and capital allocation efficiency across market cycles.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D+ • RQD 54/100): Established market leader in Financials with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 11/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 11/20, sustained execution supports upside toward the upper end of the $17.14 – $24.85 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

No upstream or downstream dependencies, sector correlations, or bottleneck links are mapped for HQH. A prospective investor should note that the absence of mapped links means this dossier cannot identify second-order ripples from the provided data.

  • Key Question #1: Can HQH sustain or expand its — operating margin and — ROIC against Finance Companies peers over the next 4 quarters?
  • Key Question #2: Will free cash flow conversion (— FCF yield) strengthen balance-sheet liquidity (Altman Z-Score N/A) toward the $24.85 52-week high?
  • Key Question #3: How sensitive is HQH's equity valuation to Financials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

HQH Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for abrdn Healthcare Investors (HQH) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to HQH Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

HQH Bull vs. Bear Conversation Board — What's Your Call at $20.99?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HQH 🐻 33% BEARISH CONVICTION
1. Pick Your Side on HQH:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MI MidwestValue RQD DEBATE OPENER • Fundamental Long-Only 🐂 BULLISH 🎯 Target: $25.03 (+17.0%)
📌 Pinned Debate

The forensic balance sheet pillar scores 13 out of 20 with an Altman Z-Score of 2.5 and a Piotroski F-Score of 6/9, indicating relative

The street is overcomplicating abrdn Healthcare Investors (HQH). The forensic balance sheet pillar scores 13 out of 20 with an Altman Z-Score of 2.5 and a Piotroski F-Score of 6/9, indicating relative balance-sheet stability.. With an RQD score of 54/100 (D+) and Forensic Balance Sheet at 13/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $23.10.

SectorRotator 🐂 BULL

@MidwestValue Agree on the RQD 54/100 quality, though with 1.0 beta I'm scaling in with half-size at $21.39 and keeping dry powder in case we test $19.89.

SH ShortSeller_Dan RQD DEBATE OPENER • Forensic Short Bias 🐻 BEARISH 🎯 Target: $17.11 (-20.0%)
Spot @ $21.39

Reported ROIC and FCF yield are both 0%, and insider conviction scores only 9 out of 20, leaving the rating without demonstrated cash r

Reported ROIC and FCF yield are both 0%, and insider conviction scores only 9 out of 20, leaving the rating without demonstrated cash returns or visible insider support.. Look at the math on HQH: paying current EV/EBITDA multiples for 0.0% ROIC and 0.0% operating margins leaves zero margin of safety if Finance Companies demand softens. I'd wait for a retest of $18.82 before getting long.

LIVE TAPE